AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BARICITINIB 4 Mg ;

10 registrations across 1 African market— 10 active

Markets with BARICITINIB 4 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Kubalexen
Film Coated Tablets
🇪🇬EgyptOmega Pharmaactive
Baritava 4mg
Film Coated Tablets
🇪🇬EgyptHikma pharmaactive
Kubalexen
Film Coated Tablets
🇪🇬EgyptOmega Pharmaactive
Barcimiant 4 mg
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Andomatoid 4 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Baritava 4mg
Film Coated Tablets
🇪🇬EgyptHikma pharmaactive
Andomatoid 4 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Barcimiant 4 mg
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Barictomap 4 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive
Barictomap 4 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive

BARICITINIB 4 Mg ; in Africa — Regulatory Overview

BARICITINIB 4 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.